内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Carter Todd Alfred. Director active across 1 company, notably Voyager Therapeutics, Inc.. Aggregated, 18 reports have been published. Split: 0 buy · 12 sells. Total volume traded: €172k. History available since 31 December 2022. The latest transaction was disclosed on 24 February 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Carter Todd Alfred
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
4,174 股@ US$3.766.6% 占其流量Common StockSEC:0001104659-26-020176:0
3,301 股@ US$3.444.8% 占其流量Common StockSEC:0001104659-26-018130:0
3,525 股@ US$3.855.7% 占其流量Common StockSEC:0001104659-26-013408:0
33,000 股0Common StockSEC:0001104659-26-012677:0
3,305 股@ US$4.268.1% 占其流量Common StockSEC:0001104659-25-016522:0
5,413 股@ US$4.4514.1% 占其流量Common StockSEC:0001104659-25-012200:0
1,191 股@ US$5.133.6% 占其流量Common StockSEC:0001104659-25-003772:0
602 股@ US$7.682.6% 占其流量Common StockSEC:0001104659-24-026554:0
38,500 股0Common StockSEC:0001104659-24-024993:0
1,266 股@ US$7.185.0% 占其流量Common StockSEC:0001104659-24-005244:0
5,000 股@ US$2.8512.1% 占其流量Common StockSEC:0001104659-23-101631:0
5,500 股@ US$10.8032.8% 占其流量Common StockSEC:0001104659-23-079686:0
5,000 股@ US$2.857.9% 占其流量Common StockSEC:0001104659-23-078152:0
2,193 股@ US$7.769.6% 占其流量Common StockSEC:0001104659-23-035642:0
34,000 股0Common StockSEC:0001104659-23-024423:0
797 股@ US$7.673.4% 占其流量Common StockSEC:0001104659-23-022430:0
706 股@ US$9.573.8% 占其流量Common StockSEC:0001104659-23-005050:0
388 股@ US$5.171.1% 占其流量Common StockSEC:0001104659-23-002718:0
About Carter Todd Alfred
Carter Todd Alfred is a declarant linked to Voyager Therapeutics, Inc., where he is Chief Scientific Officer. He has 18 filings in total, and within the recent filings covered here, the transactions are entirely sales, for a total of EUR 172222 between 2023-01-10 and 2026-02-26.